Published in ScientificWorldJournal on October 21, 2013
Assessment of cardiovascular risk factors in people with HIV infection treated with ART in rural South Africa: a cross sectional study. AIDS Res Ther (2015) 0.84
Metabolic syndrome, diabetes, and cardiovascular risk in HIV. Curr HIV/AIDS Rep (2014) 0.83
The association between alcohol use and cardiovascular disease among people living with HIV: a systematic review. Am J Drug Alcohol Abuse (2015) 0.78
Ideal Cardiovascular Health and Carotid Atherosclerosis in a Mixed Cohort of HIV-Infected and Uninfected Ugandans. AIDS Res Hum Retroviruses (2016) 0.75
Incidence of Diabetes Mellitus and Obesity and the Overlap of Comorbidities in HIV+ Hispanics Initiating Antiretroviral Therapy. PLoS One (2016) 0.75
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK. J Int AIDS Soc (2016) 0.75
Serum lipid and glucose profiles in HIV-positive Nigerian children. J Virus Erad (2017) 0.75
Relationship between estimated cardiovascular disease risk and insulin resistance in a black African population living with HIV: a cross-sectional study from Cameroon. BMJ Open (2017) 0.75
CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation. J Acquir Immune Defic Syndr (2017) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet (2010) 12.82
High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol (1990) 12.64
Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med (2003) 12.23
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation (2003) 8.29
Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet (2003) 7.94
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2011) 6.36
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation (2002) 6.20
[VI Brazilian Guidelines on Hypertension]. Arq Bras Cardiol (2010) 4.17
Standards of medical care in diabetes. Diabetes Care (2004) 3.95
Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med (1983) 3.32
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil (2010) 2.70
Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis (2007) 2.55
[IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology]. Arq Bras Cardiol (2007) 2.19
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. HIV Med (2008) 1.54
Coronary heart disease risk assessment in HIV-infected patients: a comparison of Framingham, PROCAM and SCORE risk assessment functions. Int J Clin Pract (2010) 1.53
[AIDS epidemic trends after the introduction of antiretroviral therapy in Brazil]. Rev Saude Publica (2006) 1.53
[A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results]. Rev Esp Cardiol (2005) 1.31
HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS (2008) 1.24
Cardiovascular complications in HIV management: past, present, and future. J Acquir Immune Defic Syndr (2009) 1.20
Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials (2010) 1.16
Differential survival benefit of universal HAART access in Brazil: a nation-wide comparison of injecting drug users versus men who have sex with men. J Acquir Immune Defic Syndr (2009) 1.15
The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients. Atherosclerosis (2006) 1.14
Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population. J Infect Dis (2012) 1.09
Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART. Braz J Infect Dis (2010) 1.02
Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE, and PROCAM). AIDS Patient Care STDS (2007) 1.02
Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais. HIV Med (2011) 0.98
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men. Int J Epidemiol (2007) 0.96
Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution. Int J Vasc Med (2011) 0.95
The metabolic syndrome in HIV. Best Pract Res Clin Endocrinol Metab (2011) 0.94
Elevated triglycerides and risk of myocardial infarction in HIV-positive persons. AIDS (2011) 0.89
Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil. Metab Syndr Relat Disord (2010) 0.87
Can the risk of cardiovascular disease in HIV-infected patients be estimated from conventional risk prediction tools? Clin Infect Dis (2007) 0.87
Lipid metabolism in treated HIV Infection. Best Pract Res Clin Endocrinol Metab (2011) 0.85
Metabolic abnormalities and coronary heart disease risk in human immunodeficiency virus-infected adults. Metab Syndr Relat Disord (2010) 0.85
Lipid profile, cardiovascular risk factors and metabolic syndrome in a group of AIDS patients. Arq Bras Cardiol (2009) 0.82
Dyslipidemia in AIDS patients on highly active antiretroviral therapy. Braz J Infect Dis (2011) 0.82
Cardiovascular prevention in HIV patients: results from a successful intervention program. Atherosclerosis (2008) 0.81
Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease. Int J Clin Pract (2007) 0.80
Cardiovascular risk and dyslipidemia management in HIV-infected patients. Top Antivir Med (2012) 0.80
Dengue and dengue hemorrhagic fever, Brazil, 1981-2002. Emerg Infect Dis (2005) 2.53
Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil. Int J Epidemiol (2008) 1.21
Low sensitivity of NS1 protein tests evidenced during a dengue type 2 virus outbreak in Santos, Brazil, in 2010. Clin Vaccine Immunol (2012) 1.06
Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil. Cad Saude Publica (2010) 0.99
Population-based surveillance of pediatric pneumonia: use of spatial analysis in an urban area of Central Brazil. Cad Saude Publica (2004) 0.99
Laboratory surveillance of dengue virus in Central Brazil, 1994-2003. J Clin Virol (2006) 0.98
Evaluation of a commercial real-time PCR kit for detection of dengue virus in samples collected during an outbreak in Goiania, Central Brazil, in 2005. J Clin Microbiol (2007) 0.95
Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context. Vaccine (2012) 0.93
Genetic diversity and HIV-1 incidence estimation among cocaine users in São Paulo, Brazil. J Acquir Immune Defic Syndr (2002) 0.91
Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil. Int J Epidemiol (2004) 0.90
[Factors associated with poor self-rated health in elderly users of the Brazilian Unified National Health System]. Cad Saude Publica (2011) 0.84
Mother-to-child transmission of HIV: risk factors and missed opportunities for prevention among pregnant women attending health services in Goiânia, Goiás State, Brazil. Cad Saude Publica (2007) 0.83
Prevalence of cardiovascular risk factors in elderly individuals treated in the Brazilian Public Health System in Goiânia. Arq Bras Cardiol (2010) 0.83
Dyslipidemia in AIDS patients on highly active antiretroviral therapy. Braz J Infect Dis (2011) 0.82
[The profile of hospitalizations and associated factors among elderly users of the Brazilian Unified Health System (SUS)]. Cien Saude Colet (2013) 0.80
Prevalence, genotype profile and risk factors for multiple human papillomavirus cervical infection in unimmunized female adolescents in Goiânia, Brazil: a community-based study. BMC Public Health (2013) 0.80
Transmitted HIV resistance among pregnant young women infected with HIV-1 in Brazil. AIDS Patient Care STDS (2013) 0.80
Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs. Braz J Infect Dis (2012) 0.80
Relationship between sitting-height-to-stature ratio and adiposity in Brazilian women. Am J Hum Biol (2005) 0.80
Peristomal infection in percutaneous endoscopic gastrostomy (PEG): a comparative study of two gastropexy techniques in a before-and-after design. Acta Gastroenterol Latinoam (2011) 0.79
Estimated incidence and genotypes of HIV-1 among pregnant women in central Brazil. PLoS One (2013) 0.78
[Erythema nodosum leprosum case series report: clinical profile, immunological basis and treatment implemented in health services]. Rev Soc Bras Med Trop (2004) 0.78
Prevalence of Chlamydia trachomatis in asymptomatic Brazilian military conscripts. Sex Transm Dis (2005) 0.78
[Functional capacity, socioeconomic conditions and of health of elderly assisted by Family Health teams in Goiania (GO, Brazil)]. Cien Saude Colet (2010) 0.76
[Bacteremias at a teaching hospital: etiology, antimicrobial susceptibility pattern and risk factors for mortality]. Rev Assoc Med Bras (2007) 0.75
Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil. Cad Saude Publica (2012) 0.75
[Factors associated with minor psychiatric disorders among women selected from a healthcare center in Rio de Janeiro, Brazil]. Cad Saude Publica (2006) 0.75
[Nutritional therapy in metabolic changes in individuals with HIV/AIDS]. Rev Saude Publica (2012) 0.75